80
Participants
Start Date
November 30, 2021
Primary Completion Date
May 22, 2024
Study Completion Date
May 22, 2024
LBL-007 Injection
LBL-007 Injection; dose A or dose B; Q3W
Toripalimab Injection
Toripalimab Injection; dose C; Q3W
Changzhou Cancer Hospital, Changzhou
The first affiliated hospital of bengbu medical University, Bengbu
Qilu Hospital of Shandong University, Jinan
Affiliated Hospital of Jining Medical University, Jining
Linyi Cancer Hospital, Linyi
Tianjin Medical University Cancer Institute & Hospital, Tianjin
The 900 Hospital of the Joint Service Support Force of the People's Liberation Army of China, Fuzhou
Chongqing University Three gorges Hospital, Chongqing
Hunan Cancer Hospital, Changsha
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
Hubei Cancer Hospital, Wuhan
Henan Cancer Hospital, Zhengzhou
Sun Yat-sen University Cancer Center, Guangzhou
The First People's Hospital of Yu Lin, Yulin
Nanjing Leads Biolabs Co.,Ltd
INDUSTRY